TB-500
5mg
TB-500 is a synthetic fragment of thymosin beta-4, a protein present in virtually all human and animal cells. Research has focused on its role in cell migration, blood vessel formation and cell differentiation. TB-500 contains the active region of thymosin beta-4 responsible for actin binding and cell motility, making it one of the most referenced compounds in cell biology and wound healing research. Often studied alongside BPC-157. Supplied as lyophilised powder, third-party tested, lab certificate published on this page.
Published research on TB-500 is indexed on PubMed. See our full UK buyer's guide for TB-500.
Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance.
98%+
Purity
LAB
Certified
SAME
Day Ship
Quantity
Add £21.01 more for free UK delivery
Damaged or lost? Free reshipment guaranteed
BPC-157 + TB-500 5+5mg
Pre-blended soft-tissue research peptide vial. BPC-157 and TB-500 combined.
All components in a single lyophilised vial. One reconstitution, one inventory line, one CoA.
Research Use Only
This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.
Certificate of Analysis
Third-party tested
Lyophilised Stability
24 months
Sealed at -20°C, light-protected
Reconstituted Stability
Up to 3 months
Stored at 2-8°C after mixing
Cold-Chain Shipping
Always
Dry-cold pack, Royal Mail Tracked 24
Important Notice
All compounds are sold individually and do not include research supplies. Products are provided in lyophilised (powder) form and require proper reconstitution before use in research settings.
Related Products
Product Specifications
Research Overview
TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein that occurs naturally in blood platelets, wound fluid, and virtually all nucleated mammalian cells. Research on TB-500 concentrates on its roles in actin regulation, cellular migration, and systemic tissue repair processes. The compound is distinguished from BPC-157 by its systemic mechanism of action, while BPC-157 is thought to act locally at injury sites, TB-500 promotes cell migration and differentiation throughout the body by sequestering G-actin monomers and regulating cytoskeletal dynamics. This systemic activity has led to extensive research in wound healing models, cardiac tissue repair following ischaemic events, hair follicle regeneration, and inflammatory response modulation. TB-500 contains the active domain of Thymosin Beta-4 responsible for actin binding and cell motility, making it a critical research tool in cell biology. Studies have examined its ability to promote endothelial cell migration, keratinocyte migration, and collagen deposition in various preclinical wound models. The compound's role in modulating inflammatory cytokines adds a further dimension to its research profile.
Product Specifications
Laboratory Handling
- Store lyophilised vials at -20°C. Reconstituted TB-500 should be kept at 2-8°C and used within 4 weeks.
- Reconstitute with bacteriostatic water using gentle swirling. Do not vortex to preserve peptide integrity.
- Use aseptic technique during all handling. Sterilise injection surfaces with alcohol swabs before piercing vial stoppers.
- Aliquot reconstituted solution to avoid repeated freeze-thaw cycles which can reduce peptide activity.
Frequently Asked Questions
TB-500
5mg · £23.99